Next generation sequencing and imprinting disorders: Current applications and future perspectives: Lessons from Silver-Russell syndrome.

Imprinting disorders Longread NGS Next generation sequencing Silver-Russell syndrome Whole exome sequencing Whole genome sequencing

Journal

Molecular and cellular probes
ISSN: 1096-1194
Titre abrégé: Mol Cell Probes
Pays: England
ID NLM: 8709751

Informations de publication

Date de publication:
04 2019
Historique:
received: 12 10 2018
revised: 05 12 2018
accepted: 22 12 2018
pubmed: 6 1 2019
medline: 7 5 2019
entrez: 6 1 2019
Statut: ppublish

Résumé

Imprinting Disorders are a group of rare diseases with overlapping phenotypes which are associated with similar molecular changes and affect imprinted chromosomal regions. Clinical features mainly occur prenatally or in childhood, but have a severe lifelong impact on health. Due to their clinical and molecular heterogeneity, the diagnosis of imprinting disorders is often challenging and requires testing of a broad spectrum of genomic variants and aberrant methylation of imprinted loci (epimutations). A significant number of patients suspicious for imprinting disorders remain without a molecular confirmation, and in these cases differential diagnoses have to be considered. In fact, in patients with clinical features suggestive for imprinting disorders, the precise identification of the molecular cause is relevant for both clinical management as well as for genetic counselling. Thus, a comprehensive testing approach has to be applied. Next generation sequencing (NGS) based studies show that this technique is a valuable tool to improve the diagnostic efficiency particularly in entities with broad differential diagnoses. Furthermore, the development of diverse NGS approaches allows new insights in the function of imprinted regions, their structures, interactions and regulation. Based on a large cohort of patients referred for routine Silver Russel syndrome testing, the appropriateness and limitations of first trial tests in imprinting disorders are demonstrated in this report, but the chances of genomic NGS approaches for diagnostics and research are elucidated as well. Finally, the significance of the precise molecular diagnosis for the personalized management of the patient, and genetic counselling of the family will be discussed.

Identifiants

pubmed: 30610903
pii: S0890-8508(18)30267-6
doi: 10.1016/j.mcp.2018.12.007
pii:
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Lea Neuheuser (L)

Institute of Human Genetics, University Hospital, Technical University RWTH, Aachen, Germany.

Robert Meyer (R)

Institute of Human Genetics, University Hospital, Technical University RWTH, Aachen, Germany.

Matthias Begemann (M)

Institute of Human Genetics, University Hospital, Technical University RWTH, Aachen, Germany.

Miriam Elbracht (M)

Institute of Human Genetics, University Hospital, Technical University RWTH, Aachen, Germany.

Thomas Eggermann (T)

Institute of Human Genetics, University Hospital, Technical University RWTH, Aachen, Germany. Electronic address: teggermann@ukaachen.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH